Literature DB >> 18275578

Abdominopelvic tuberculosis in gynaecology: laparoscopical and new laboratory findings.

Andrea Tinelli1, Antonio Malvasi, Daniele Vergara, Roberta Martignago, Giuseppe Nicolardi, Raffaele Tinelli, Marcello Pellegrino.   

Abstract

INTRODUCTION: Tuberculosis (TB) is a rare curable infective disease, caused mainly by Mycobacterium tuberculosis, which in abdominopelvic (AP) localisation, can mimic a disseminated carcinomatosis. Symptoms of AP-TB are non-specific, so diagnosis is difficult and elusive as the affected patients have normal chest X-ray and elevated levels of CA125. Female ultrasonographic features of AP-TB mimic peritoneal carcinomatosis, and the computed tomography has also been suggested to be helpful, but the final diagnosis was reached by histology and serology. AIM OF THE STUDY: To propose the validity of the combination of laparoscopy (LPS), histopathology and enzyme-linked immuno-spot (ELIspot) in the diagnosis of AP-TB.
METHODS: In the last two years, we had six women with suspect of AP-TB, who, after the routine exams, were referred for a diagnostic LPS that revealed turbid-free fluid in pelvis or ascites (collected for serology), multiple peritoneal and/or bowel tubercles (randomly sampled), fibrous bands, adhesions, hyperaemic and oedematous bowel loops.
RESULTS: LPS diagnosis was confirmed by intra-LPS biopsy of nodules and histological examination of specimens: epithelioid granulomas with central caseous necrosis in five patients (83.3%) and a non-caseating granulomatous inflammation in the last one. An outer layer of epithelioid histiocytes and Langhans cells was present in all patients. Using the ELIspot technique performed on free fluids, the final diagnosis of TB was made in all patients.
CONCLUSIONS: Even if gynaecological LPS appearance of the peritoneum can mimic other conditions, ELIspot and histopathological exam can confirm the suspect of AP-TB.

Entities:  

Mesh:

Year:  2008        PMID: 18275578     DOI: 10.1111/j.1479-828X.2007.00800.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  8 in total

Review 1.  The immunology of tuberculosis: from bench to bedside.

Authors:  Keertan Dheda; Stephan K Schwander; Bingdong Zhu; Richard N van Zyl-Smit; Ying Zhang
Journal:  Respirology       Date:  2010-04       Impact factor: 6.424

2.  Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention.

Authors:  Muhsin Kaya; Mehmet A Kaplan; Abdurrahman Isikdogan; Yusuf Celik
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

3.  Screening for genital tuberculosis in a limited resource country: case report.

Authors:  Sadie Namani; Emine Qehaja-Buçaj; Diellëza Namani
Journal:  BMC Infect Dis       Date:  2017-02-07       Impact factor: 3.090

4.  Abdominopelvic Tuberculosis with a Frozen Section Analysis Consistent with Ovarian Cancer.

Authors:  Agrimaldo Martins-Filho; Paula Carolina Arvelos Crispim; Renata Margarida Etchebehere; Cristina da Cunha Hueb Barata de Oliveira; Eddie Fernando Candido Murta; Rosekeila Simões Nomelini
Journal:  Case Rep Infect Dis       Date:  2017-04-09

5.  Adnexal Mass with Ascites and High Cancer Antigen -125 in a Young Female: Not Always Malignancy!

Authors:  Gyanendra Chaudhary; Enono Yhoshu; Intezar Ahmed
Journal:  J Indian Assoc Pediatr Surg       Date:  2020-09-01

6.  Familial tuberculosis mimicking advanced ovarian cancer.

Authors:  Fakhrolmolouk Yassaee; Farah Farzaneh
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-21

7.  Female genital tract tuberculosis presenting as ovarian cancer.

Authors:  Malihe Hasanzadeh; Hamid Reza Naderi; Azamossadat Hoseine Hoshyar; Shima Shabane; Soodabeh Shahidsales
Journal:  J Res Med Sci       Date:  2014-02       Impact factor: 1.852

8.  Incidental Finding of Intraperitoneal Tuberculosis in a Patient Presenting with a Large Ovarian Mass.

Authors:  Ayla Green; Samer Elmasry; Himali Ihalagama; Saman Senaratne
Journal:  Case Rep Infect Dis       Date:  2018-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.